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Summary 
In recent years there has been much progress in the field of synthetic biology, 
wherein biological processes and systems are de-constructed and re-engineered to 
display novel functions that may not exist in nature. Molecular motors, rotors and 
artificial cell constructs utilising basic building blocks derived from nature have 
been constructed. Such biologically-inspired devices require a compatible source 
of energy such as ATP in order to function and do useful work. The long-term 
operation of such devices will depend critically on the self-sustainable conversion 
of energy sources into ATP.  
 
The goal of my research is to evaluate a coupled bacteriorhodopsin (BR)-ATP 
synthase system and develop it as a light-driven system for ATP synthesis, 
capable of being harnessed to power ATP-dependent enzymatic processes and 
devices. Harnessing the relatively limitless power of sunlight and recycling of the 
biological energy carrier ATP/ADP enables a clean and long-term operation, 
while more advanced control over the light source enables extremely sophisticated 
modulation of the device operation. In this work, the foundations for the 
extraction and purification of BR and TF1Fo ATP synthase, and directional co-
incorporation into phospholipid vesicles via detergent mediation were established. 
The pumping of H+ by BR into the liposome lumen upon light illumination is also 
demonstrated. Issues regarding the complex purification of the TF1Fo ATP 
synthase membrane protein via anion exchange chromatography and fractional 
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Chapter 1: Introduction and Literature Review  
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1.1 Synthetic Biology 
In recent years there has been a great interest in synthetic biology, wherein 
biological processes and systems are de-constructed and re-engineered to display 
novel functions that may not exist in nature. By mimicking these biological 
processes or manipulating their functional components, unique molecular 
architectures could be built that can: convert and transduce energy, perform 
mechanical work, synthesize specialist chemicals or drugs, store information, 
sense, signal, self-assemble and reproduce at the nanoscale or molecular level. 
Already, rudimentary synthetic systems such as actin-myosin molecular motors1, 
ATP synthase rotors2, artificial cells3 and other molecular devices have been 
demonstrated. These systems, borrowed from natural building blocks that have 
been refined through millions of years of evolutionary processes, are often highly 
efficient, and perform better than any analogous device manufactured using 
traditional fabrication techniques. Constructed on a molecular or nanoscale level, 
the bottom-up, self-assembly methods of fabrication used are expected to allow 
greater precision and flexibility in the manufacture of nanoscale devices, at 
dimensions beyond the fabrication limits of conventional lithographic techniques, 
and at a lower cost than traditional manufacturing processes.  
 
1.2 The need for ATP as a Source of Energy 
Such biologically-inspired devices require a compatible source of energy in order 
to function and do useful work. In living cells and most biological processes, 
adenosine 5’-triphosphate (ATP) is the universal energy currency used. Energy is 
liberated from ATP by a reaction that cleaves one of the high-energy 
phosphoanhydride bonds to form ADP and a phosphate: 
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ATP + H2O → ADP + Pi     ∆G = -36.8 kJ/mol 
 
This energy released is used to power virtually every metabolic activity of the 
cell and organism, such as cellular growth, maintenance and replication, active 
transport of ions and molecules across cell membranes, electrical impulse 
generation in nerves and actin-myosin fibril movement in muscle contractions.   
 
1.3 Control Issues 
Another important issue is the engineering of control mechanisms into these 
devices, such as being able to start and stop operation and regulate the supply of 
energy. In motility and functionality assays reported on molecular motors1 and 
artificial cell bioreactors3, the issue of ATP regulation is usually sidestepped by 
supplying ATP externally into the buffer solution. While useful for rudimentary 
demonstrations of motility and function, little control is possible, and uncontrolled 
enzyme activity usually proceeds until all the ATP runs out. Complications can 
occur as high concentrations of ATP, or its waste product, ADP, have been 
reported to inhibit enzymatic activity4. If the enzyme is under some form of 
encapsulation or protective barrier, permeability5 issues are also a potential 
problem.  
 
Hence, for the long-term operation of more complex molecular devices, continual 
supply of the right amounts of ATP, as well as the recycling of waste ADP, are 
required. Control mechanisms to start and stop these devices also need to be 
incorporated. External supply of ATP does not address these problems adequately 
and do not address the problem of long-term sustainability.  
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1.4  Approaches to Light-Transduction of Energy 
Conventionally, solar energy is harnessed through a variety of methods, such as 
through photovoltaic cells that generate electricity, or thermal collectors that 
concentrate heat from the sun. Solar energy is also converted to storable forms by 
utilizing generated electrical output to charge and recharge batteries. Recently, 
there has also been increasing success in the use of photosynthetic 
microorganisms to generate biomass or biohydrogen. Photosynthetic microalgae 
produce biomass rich in oil that can be subsequently converted to biodiesel6. 
Other photosynthetic bacteria are used to produce hydrogen via fermentation from 
bio-mass derived sugars7. 
 
However, powering devices on a nanoscale and molecular level requires a 
different paradigm for energy transduction due to their small size and unique 
energy supply requirements. Biologically-derived motor proteins and enzymes 
often require a biocompatible source of energy, usually a proton motive force or 
ATP, in order to perform useful work or metabolic processes. Demonstrations of 
their function are usually enabled by adding ATP into the mixture and letting the 
devices run until the fuel runs out. There have been attempts at keeping ATP 
levels high using enzymatic ATP regenerating systems8 based around pyruvate 
kinase and acetate kinase. However, these methods merely transfer the burden of 
fuel limitation to another enzymatic substrate necessary for ADP regeneration.  
Others have attempted a form of light-to-ATP energy transduction through the 
photolysis of caged ATP9. While this confers an element of control over its release, 
like the previous methods there is no long-term regeneration of ATP.  From a 
purely synthetic approach, chemists have also approached the problem by 
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bypassing the requirement of ATP, through the designing of light sensitivity into 
the molecular structure itself. Organic photo-reactive molecular motors10 have 
been synthesized which respond physically to light to perform useful work such as 
linear or rotary motion.  However, while a variety of such different chemical 
analogues have been created; they do not surpass what nature has to offer in terms 
of variety and efficiency. 
 
Fortunately, for the long-term regeneration of ATP we need look no further than 
to nature, which has developed a highly efficient system of ATP synthesis through 
3 billion years of evolution. ATP is used as a primary energy source by most 
living species on Earth, including us. The human body generates over 50 kg of 
ATP every day to provide energy for various biochemical reactions. In plants and 
bacteria, the similar processes are used to transduce light energy into ATP and 
carbon biomass via photosynthesis. By taking a biomimetic approach and 
modelling these processes, light transduction of solar energy into ATP can be 
replicated and incorporated into artificial systems.  
 
1.5 ATP Synthesis: ATP Synthase 
The production of ATP in all living systems occurs via the ATP synthase enzyme. 
ATP synthase is a ubiquitous membrane protein that is found in energy-
transducing membranes, such as the inner membrane of mitochondria in 
eukaryotic cells, cytoplasmic plasma membranes of eu- and archaebacteria, and 
thylakoid membranes of plant chloroplasts. The enzyme is a large 500 kDa protein 
complex composed of two major subunits that act as two opposing rotary motors; 
a membrane-embedded F0 (ab2c10-12) sector, and a soluble F1 (α3β3γδε) sector that 
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catalyses ATP synthesis or 
hydrolysis. (Fig. 1) The two sectors 
are physically connected by two 
stalks, a central one containing the γ 
and ε subunits, and a peripheral one 
comprising δ and b subunits. 
 
ATP synthesis is the main role of the 
enzyme in eukaryotic organisms, 
where it utilizes the proton gradient 
generated by electron-transport 
chains to power the synthesis of ATP from ADP. Under a proton gradient, protons 
flow through the interface channel of the Fo a and c subunits, creating a torque 
between them that drives the rotation of the γ shaft and ε subunit. This alternates 
the conformation of the β-subunit in F1 so that ATP is synthesized. In bacterial 
species ATP synthase can also work in reverse by hydrolyzing ATP to generate a 
proton gradient. ATP hydrolysis by F1 drives the rotation of γ in the opposite 
direction, to cause the pumping of H+ through Fo in the opposite direction.  In this 
way, many important proton-gradient dependent functions, such as flagella 
motility or transmembrane ion transport, can be supported.  
 
1.6  ATP Synthesis: Generation of Proton Gradient  
1.6.1 Citric Acid Cycle 
Energy stored by a trans-membrane electrochemical proton gradient is utilized by 
the ATP synthase enzyme to generate ATP. In the mitochondria of eukaryotic 
Fig. 1. 3-D model of F1F0 ATP synthase 
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cells, this proton gradient is generated by the electron transport chain, a series of 
spatially separated redox reactions in which electrons are transferred from a donor 
to an acceptor molecule. The generation of ATP via ATP synthase starts with the 
citric acid cycle. Briefly, pyruvate and fatty acids generated through glycolysis of 
fats and sugars in the cell pass through the cytosol into mitochondria and are 
converted to the metabolic intermediate acetyl Co-enzyme A (CoA). CoA is then 
enzymatically decarboxylated through the citric acid cycle to form CO2, which 
diffuses out of the organelle as a waste product. More importantly, the cycle 
generates the high energy activated carrier molecules Nicotinamide adenine 
dinucleotide (NADH) and 1,5-dihydro- flavin adenine dinucleotide (FADH2). 
These molecules are transported into the inner mitochondrial membrane and enter 
the electron transport chain. The electrons they carry are then passed sequentially 
through other proteins in the electron transport chain, resulting in the uptake of H+ 
ions across and into the inner mitochondrial membrane. This resulting proton 
gradient drives H+ back out through ATP synthase and catalyses the synthesis of 
ATP from ADP and Pi. The entire process, in which O2 is utilised in the final step 




Chloroplast organelles are responsible for the photosynthetic reactions in plant 
cells. The main photosynthetic components in the chloroplast are the thylakoid 
membranes, where all the light-dependent reactions of photosynthesis occur. 
Light-sensitive chlorophyll and carotenoid pigments are embedded into the 
thylakoid membranes as large arrays of light-harvesting antenna systems. These 
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Fig. 2.  3-D model of 7 α-helix transmembrane 
bacteriorhodopsin 
 
systems absorb light and funnel the excitation energy to Reaction Centres (RCs), 
classified Photosystem I and Photosystem II, where a series of electron transfer 
reactions occur. The resulting reactions lead to the oxidation of water into 
hydrogen ions and molecular oxygen (termed oxygenative photosynthesis), and 
the generation of a proton gradient across a cell membrane by the transmembrane 
cytochrome c complex, which in turn powers the biosynthesis of ATP and NADH. 
Both ATP and NADH are subsequently utilized in the Calvin Cycle to fix CO2 
into carbohydrates.  
 
1.6.3 Proton pumps and Bacteriorhodopsin  
Light-sensitive proton pumps present in photosynthetic bacteria, such as the 
halophilic archaea and proteobacteria, transport a proton across a cell membrane 
through a series of light-induced conformational changes.   Bacteriorhodopsin 
(BR) (Fig. 2), a single protein which occurs in the purple membrane (PM) of the 
archaebacteria Halobacterium Salinarum, is a 26 kD, seven membrane helical 
protein with a retinal chromophore attached to the protein via a Schiff base. It 
functions as a light-driven 
unidirectional proton pump, 
absorbing energy from the 
visible spectrum of light with a 
peak absorption at 560 nm that 
gives it its characteristic purple 
coloration. H+ transfer across the 
membrane occurs via a series of 
cyclic conformational changes. 
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Extensive study has been done on the conformational changes and photocycle of 
BR. For reviews, see 11,12. Coupled to ATP synthase, BR can serve as an alternate 
pathway for non-oxidative phosphorylation of ATP synthesis13. 
 
1.7 Artificial Transduction of Light Energy 
Through the photosynthetic process, Nature offers us many examples for the 
transduction of solar energy into various forms such as electron charge separation, 
generation of transmembrane proton motive force, ATP synthesis as well as 
biofuel production through carbon fixation. By mimicking these principles, 
photosynthetic reactions in artificially engineered systems has been achieved. For 
example, chemical analogues mimicking these principles, such as the covalently 
linked porphyrin-quinone (P-Q) molecular dyad, have been synthesized14,15 and 
demonstrated to perform photoinduced charge separation and electron transfer 
reactions capable of generating photoelectric currents. Recently, it was also 
demonstrated that the photosynthetic reaction centres of purple bacterium 
Rhodobacter sphaeroides could be isolated and reconstituted in phospholipid 
nanodiscs to form complex photoelectrochemical nanostructures capable of 









1.8 ATP Synthase and Bacteriorhodopsin 
Manipulation of the plant photosystems requires the careful handling of many 
different protein complexes and their interconnected enzymatic reactions. 
However, the structurally simpler light-sensitive proton pumps provide a less 
complex way to harness light or solar energy. By coupling the resulting proton 
motive force to ATP synthase, non-spontaneous reactions such as biochemical 
synthesis, mechanical work and transport processes can be powered. Research on 
the functional activity of ATP synthase has made use of the chemiosmotic 
coupling of BR, a light-driven H+ pump, and F1F0 ATP synthase from various 
sources to generate a stable proton gradient supply with which to drive ATP 
synthesis (Fig. 3). Simple prototypes of these have been constructed since the 
early 70s to study the 
functional activity of both BR 
and ATP synthases13,17. The 
first reports of using BR and 
F1F0 ATP synthase were 
performed by Racker et al13 to 
study the thermodynamic and 
kinetic mechanisms of BR and 
ATP synthase, as well as 
provide a working model for 
energy conversion according to 
the chemiosmotic hypothesis. 
This model is attractive for 
several reasons: 1) it can be 
Fig. 3. Bacteriorhodopsin and F1F0 ATP synthase 
embedded in a liposomal membrane. Photonic 
activation of the BR protein induces the pumping 
of H
+
 into the interior of the liposome. A reverse 
flow of the protons through the ATP synthase 
induces the synthesis of ATP from ADP and Pi. 
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purified relatively easily and integrated into liposomes in a unidirectional 
orientation, 2) it uses a clean substrate, i.e. light, to generate the proton gradient. 
 
The complex relationship between BR and ATP synthase incorporated into 
liposomes was systematically explored by Pitard et al18,19, who optimised 
principles for the detergent-mediated reconstitution of BR and ATP synthase from 
a thermophilic bacteria Bacillus PS3 into a phospholipid vesicle membrane. This 
thermally stable construct is able to generate a long-lasting light-driven ATP 
synthesis.  Luo et al20 further demonstrates the stabilization of the 
proteoliposomes with a sol-gel matrix against proteases. Others have also started 
developing the potential of this ATP generation system for use in powering high-
order nanomolecular devices in biological systems21.  
 
1.9 Aims and Objectives 
The aim of this project was to evaluate a coupled BR-ATP synthase system and 
develop it as a light-driven system for ATP synthesis, capable of being harnessed 
to power ATP-dependent enzymatic processes and devices. This system should 
enable the continuous and long-term regeneration of ATP from ADP through the 
transduction of light energy, which will confer on the system precise control of 
ATP synthesis through the regulation of area, time and intensity of light 
illumination.  
 
The specific hypothesis is that a proteoliposome embedded with BR and 
thermophilic F1Fo (T F1Fo) ATP synthase membrane proteins is a stable and long-
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lasting platform capable of light-driven synthesis and regeneration of ATP for the 
use of ATP-dependent biological processes.  
 
The hypothesis is based on the following observations: 
 
Firstly, BR and F1Fo ATP synthase have been extensively studied and there is a 
large body of data regarding their structural and functional behaviour12, 22. The 
light-sensitive BR is the smallest and simplest of the light-harvesting proteins, 
absorbing energy from the visible spectrum of light to pump H+ ions across a cell 
membrane. Its inherent robustness, structural simplicity and ease of purification as 
compared to the more complicated photosynthetic reaction centers found in plant 
chloroplasts makes BR an ideal model for the study. F1F0 ATP synthase is a 
ubiquitous membrane protein that synthesizes ATP using the stored energy of the 
electrochemical proton gradient across a cell membrane. Thermophilic F1F0 ATP 
synthase, harvested from the hot-spring residing bacteria Bacillus PS3, has been 
found to be extremely stable, even at temperatures up to 75 °C 23. Both BR and 
F1F0 ATP synthase proteins have been reconstituted model systems for the study 
of their functional activity18. It was also found that such systems retain their 
function for a few months18. 
 
Secondly, the use of light as a source of energy confers the system several 
advantages. The harnessing of sunlight essentially taps on a free and unlimited 
energy source, drawing parallels with solar cells and other photovoltaic devices 
with respect to their potential applications. The use of light also confers the 
system precise control24 that is much desired in complex nano-machinery. 
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Photonic regulation of ATP production can be achieved by varying its intensity 
and illumination time, while spatial control can be achieved using lasers and other 
precision light sources. The regeneration of ATP from used ADP in a closed 
system also negates the need for continual replenishment of ATP and the removal 
of waste product.  
  
 The main challenge of this project is to successfully isolate the unit protein 
components of the system from its natural sources, ensure the optimal production 
of ATP synthesis and confer mechanical and biological stability to the 
proteoliposome. Based on these observations, the focus of this proposal is to 
synthesize this polymer-proteoliposome system and evaluate its long-term 
viability as a platform for light-driven ATP synthesis. 
 
The specific aims are: 
 
1) Extraction, purification and assay of BR and F1F0 ATP synthase membrane 
proteins.  It is essential that the BR and F1F0 ATP synthase proteins retain a 
high level of activity after its isolation and purification. BR must retain its 
proton pumping capacity, while the F1 and F0 portions of the ATP synthase 
must remain attached to each other. F1 must retain its ATP hydrolytic 
capability. To maintain consistency in experimental design, liposomes formed 
should have a uniform size distribution.  
• BR from the purple membrane (PM) of the halophilic archaea 
Halobacterium Salinarum S9 will be extracted and purified via 
ultracentrifugation. 
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• Thermophilic F1F0 ATP synthase from the bacteria Bacillus PS3 will 
be extracted and purified through Diethylaminoethyl cellulose (DEAE) 
ion exchange chromatography. F1F0 ATPase activity will be assessed 
through ATP hydrolysis assays. N,N'-dicyclohexylcarbodiimide 
(DCCD) inhibition assay will be used to monitor the catalytic F1 sector 
attachment to the membrane bound F0. 
• Purity of the extracted proteins will be assessed by Sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS PAGE). 
• Liposomes (Egg phosphatidylcholine, phosphatidic acid and 
cholesterol mixture) will be synthesized via extrusion through 
polycarbonate membranes, and size distribution will be analyzed via 
Dynamic Light Scattering (DLS). Lipid bilayer stability under the the 
influence of a detergent will be monitored with turbidity measurements 
using spectrophotometer. 
 
2) Directional incorporation of proteins into liposome, assessment of 
chemiosmotic coupling and light-driven ATP synthesis.   The efficiency of 
ATP synthesis by the proteo-liposome depends crucially on a few factors: the 
successfinsertion of the proteins in the correct orientation, ability to maintain 
an electrochemical proton gradient between the membrane, as well as on the 
optimum BR to F1F0 ATP synthase ratio. 
• The light-driven proton pumping activity of BR will by monitored via 
spectrofluorimetric methods. BR will be directionally incorporated into 
liposomes. Fluorescence quenching of pyranine encapsulated within 
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proteoliposomes upon internal acidification will indicate orientation of 
the embedded BR. 
• Light-driven ATP synthesis: Both BR and F1F0 proteins will be 
incorporated into the liposome. Light-driven ATP generation will be 
monitored under direct illumination using a standard luciferin-
luciferase ATP assay kit 
• The efficacy of ATP synthesis will be analysed by adjusting 
parameters such as protein concentration and BR/ATP synthase ratio. 
• Demonstrate efficacy of ATP producing organelle-like entity (OLE) as 
a power generating component of an ATP utilizing entity.   
 
ATP will be an important fuel source for powering future nanoscale devices 
designed around biomimetic principles. The growing development in artificial cell 
technology and nanoelectromechanical devices (NEMS) based on molecular 
motors will necessitate the need for a power cell capable of providing power for 
these purposes. We believe that the BR/F1F0 ATP synthase proteoliposome 
capsule is an elegant, efficient and robust platform which can fulfil these needs by 
a) continually producing and regenerating ATP from ADP through the 
transduction of light energy, b) enabling a precise mode of control over ATP 
synthesis and downstream elements through the regulation of light, and c) 
allowing long-term functionality through the choice of stable components and 
incorporating a protective barrier. In the long run, we propose that this platform 














2.1. Halobacterium Salinarum 
 
2.1.1. Cell Culture  
The archaebacteria Halobacterium Salinarum S9 was a kind gift from Prof. D. 
Oesterhelt’s laboratory in the Department of Membrane Biochemistry, Max 
Planck Institute for Biochemistry (MPI für Biochemie).  Culture and BR 
purification protocols are adapted from Oesterhelt et al25 and are detailed as 
follows: 
 
Halobacterium Salinarum S9 was cultured in a halophile media (HM) containing 
250 g of NaCl, 6.56 g MgSO4, 2 g KCl, 3 g Na.Citrate.2H2O and 10 g of 
bacteriological peptone (Oxoid) per litre of dd H2O, neutralized to pH 7.0 using 1 
M NaOH. The choice of Oxoid peptone is crucial as previous attempts at culturing 
the bacteria using a different brand of bacteriological peptone (Difco) failed to 
yield satisfactory results. This has also been noted by Prof. Oesterhelt’s labs 
(personal communications).  
 
The bacterial sample was cultured in a 15% agar plate and incubated at 40 oC 
under fluorescent illumination for approximately 5 days whereupon purple-
coloured colonies were observed. A colony was picked and inoculated in a starter 
culture of 35 ml of HM at 40 oC and 100 rpm shaking for 2 days, and then added 
to 1 L of HM in a 2 L Erlenmeyer flask and incubated under the same conditions. 
Bacterial growth and BR synthesis was monitored by measuring the absorbance 
optical density (OD) at 660 nm and 570 nm over a duration of 5 to 7 days, or upon 
onset of stationary phase as indicated in the growth profile. Optimal harvest time 
was determined by taking the ratio of the O.D at 570 nm against 660 nm, which is 
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indicative of the BR content per unit count of cell concentration. Cells were 
cryopreserved in 15% glycerol and stored at -80 oC. 
 
 
2.1.2 Extraction and Purification of BR  
PM was isolated from 1-litre cultures of H. Salinarum S9 first by pelleting the 
cells at 13,000 g for 15 minutes and resuspending in 100 ml of basal salt medium 
(250 g NaCl, 6.56 g MgSO4, 2 g KCl, 3 g NaCitrate.2H2O, 1 L DI H2O). 1 mg of 
DNase I (Roche) was added and the solution dialysed overnight against 2 L of 0.1 
M NaCl using a 3500 MCWO Snakeskin dialysis tubing (Pierce). The resulting 
solution was centrifuged at 40,000 g for 40 minutes, and the purple sediment was 
collected and washed 3 times with DI water and further separated via sucrose 
density gradient ultracentrifugation (see 2.2.1.3) to separate the red membrane 
from the purple membrane. The purple band in the sucrose density gradient was 
collected, and sucrose removed by dilution with 200 ml of DI water before being 
centrifuged at 50,000 g for 30 mins at 15 oC.  The BR-containing PM pellet was 
resuspended at the desired concentration with DI water and stored in the dark at 4 
oC. BR purity was assayed by SDS PAGE, and absorbance spectrum scan.  
 
2.1.3 Sucrose Density Gradient 
30 ml capacity Optiseal tubes (Beckman) were used to prepare the sucrose density 
gradient. A 60% (w/v) density-gradient grade sucrose (Merck) stock solution was 
prepared in DI water and 2 ml of it was layered in the bottom of the tube. 
Additional 5 ml layers of sucrose solutions, from 50% to 30% w/v concentration 
at 5% steps were sequentially added to a total volume of 27 ml. PM was carefully 
layered on top of the sucrose gradient and topped up with ddH2O to fill up the 
 20 
tube. The tubes were then centrifuged (L-70K, Beckman Coulter) at 100,000 g for 
17 hours at 15 oC using a SW28 swinging bucket rotor.  
 
2.2 Liposome Synthesis 
Egg phosphatidylcholine, phosphatidic acid and cholesterol (Sigma) were 
dissolved in chloroform and reconstituted in a 9:1:3 molar ratio. The solubilized 
mixture was carefully dried into a thin film on the wall of an eppendorf tube using 
a nitrogen stream, and the sample was further dried by placing in a vacuum 
concentrator (Eppendorf 5301) for at least 3 hours. PIPES buffer (20 mM, pH 7.10) 
was added to obtain a final phospholipid concentration of 18 mM: 2 mM: 6 mM 
respectively. A desired concentration of pyranine (HPTS, Sigma) will be 
supplemented into the buffer solution if the fluorescent dye is to be encapsulated. 
The mixture was vortexed and sonicated with a bath sonicator at 35 kHz (Elma 
Transonic T460/H) for 5 minutes, and then passed 10 times through a 0.4 µm 
nucleopore polycarbonate membrane using a mini-extruder system (Avanti Polar 
Lipids). If pyranine was encapsulated, the preparation will be dialysed (Snakeskin 
tubing 3500 MCWO, Pierce) overnight against the same buffer to remove 
unencapsulated  pyranine.   
 
2.2.1 Incorporation of BR into Liposomes  
BR was solubilized in 100 mM of octylglucoside (OG), sonicated for 20 secs and 
left to incubate overnight in the dark at room temperature. The pre-formed 
liposomes were treated with a sub-solubilizing amount of OG. Subsequently, BR 
was added to the liposome solution at a 40:1 w/w ratio (17.39 mg :0.43 mg per 
sample), and after an incubation time of 30 mins, detergent was removed from the 
sample via 3 sequential additions of 50, 50 and 100 mg SM2 biobeads (BioRad), 
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with 1 hour of gentle rocking after each addition. The solution was then dialyzed 
overnight against 2 L of 20 mM Piperazine-N,N'-bis (2-ethanesulfonic acid) 
(PIPES) buffer and then kept in the dark overnight before measurements. In later 
experiments, the dialysis step was omitted in order to reduce pyranine diffusion 
from within the liposomes into the bulk solution. 
 
2.3 Pyranine Optimisation Assays 
2.3.1 Fluorescence Spectrum 
Pyranine fluorescence spectrum was measured in a 96-well plate using a Gemini 
EM spectrofluorometer (Molecular Devices). 250 µl of pyranine solution of 
various concentrations at different pH were prepared. Emission wavelength was 
held at 511 nm while the excitation wavelength was scanned from 395 nm to 465 
nm.  
 
2.3.2 Generation of a Pyranine Fluorescence pH Standard Curve 
Standard 100 µM pyranine solutions in 20 mM PIPES buffer were prepared at 
different pH by adjustment with HCl and NaOH, using a pH meter. 250 µl of the 
pyranine solutions were placed in a 96-well plate. Fluorescence was measured at 
emission wavelength 511 nm and excitation wavelengths of 405 nm, 415 nm and 
450 nm. A pH standard curve is generated by plotting the ratio of fluorescence 




2.3.3 p-xylenebis(N-pyridinium bromide) (DPX) Quenching Optimization 
Fluorescence of 250 µl of 100 µM pyranine in 20 mM PIPES buffer (pH 7.2) was 
measured at excitation wavelengths 405 nm, 415 nm, 450 nm, and emission 
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wavelength 511 nm. 1 µl of 500 mM DPX is added sequentially into the well and 
allowed to equilibrate before taking fluorescence measurements.   
 
2.4 BR-liposome Proton Pumping under Light Illumination 
200 µl of dark-adapted, pyranine-encapsulated liposomes or BR-liposomes (40 
mM phospholipids in 20 mM PIPES buffer) were placed in 96-well plate and 
illuminated under an incandescent lamp. At regular time intervals, the samples 
were assayed for fluorescence at an excitation wavelength of 405 nm, 415 nm and 
450 nm, and emission at 516 nm. The emission ratio (450 nm/415 nm) was 
calculated and compared against the 450/415 fluorescence ratio vs pH of free 
pyranine standard in buffer. 20 mM of DPX (p-Xylene-bis (N-pyridinium 
bromide), Sigma) was used to quench the fluorescence of external pyranine prior 
to the illumination. 
 
2.5 TF1Fo ATP Synthase 
2.5.1 Culture of Bacillus PS3 
Bacillus PS3 was grown in a Bacillus Medium (BM) containing 8 g Peptone 
(Oxoid), 4 g yeast extract (Difco) and 3 g NaCl per liter of ddH2O. 15% bacto-
agar (Difco) was used to make the solid growth medium, and the bacteria was 
streaked onto the agar plate and incubated at 55 oC overnight. This is the maximal 
temperature allowed for growth on solid media as the agar will melt at higher 
temperatures. A 50 ml starter culture in a 200 ml conical flask was inoculated by 
picking a colony from a fresh plate and left to grow for 8 hours at 65 oC with 200 
rpm shaking. Cells were also cryopreserved in 15% glycerol BM, vortexed and 
stored at -80 oC: 
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2.5.2 Cholate Treatment and n-dodecyl β-D maltoside Detergent (NDM) 
solubilisation of F1Fo ATP Synthase 
The extraction of thermophilic F1Fo ATP synthase from the extreme thermophile 
Bacillus PS3 follows that of Montemagno et al26. Cell membranes were harvested 
from cells grown to log-phase. Lysosyme was added at 1 mg per gram of cells in 
10 ml of Standard Purification Buffer (SPB) solution (50 mM Tris-SO4, 5 mM p-
aminobenzamidine, 40 mM ε-amino n-caproic acid, 0.5 mM DTT, 0.5 mM EDTA, 
pH 8.0) per gram of cells. The cells were lysed for 30 min at 37 oC. DNA was 
hydrolyzed by incubating the viscous solution with 2 µg/ml DNase I Roche) and 5 
mM MgCl2 for 15 mins. The membranes were be centrifuged at 17,000 g for 20 
min, collected and washed 3 times with SPB, with centrifugation at 23,000 g for 
30 minutes at the end of each washing step. Total protein concentration was 
measured using the BCA protein quantitation assay (Section 2.2.7.2). The 
membrane pellet was then resuspended at a protein concentration of 10 mg/ml in 
buffer containing 0.25 M Na2SO4, and sodium cholate was added to a final 
concentration of 23 mM. The sample was then incubated for 1 hour before being 
centrifuged at 98,000 g for 40 mins. The remaining pellet contains TF1Fo and will 
be stored in minimal buffer solution containing 0.1 M sucrose and 15% glycerol 
and stored at -80 oC. Cholate-extracted protein solutions were diluted to 20 mg/ml 
and solid n-dodecyl β-D maltoside added to a final concentration of 20 mM. The 
solution was sonicated on ice for 5 min at approximately 15 W, stirred at room 





2.5.3 DEAE Anion Exchange Chromatography 
DEAE anion exchange chromatography was performed using an ÄKTAprime 
FPLC system (GE Healthcare). The solubilized protein was loaded into a DEAE 
anion exchange column (16/10 FF HiPrep, GE Healthcare) and equilibrated with 
of column loading buffer (LoB) (SPB containing 1% w/v of n-dodecyl β-D 
maltoside). Column was washed with 2 column volumes (CV) of LoB. Proteins 
were eluted out and collected in 10ml fractions using a gradient elution from 0 
mM (0% Elution Buffer(ElB)) to 410 mM Na2SO4 (82% ElB) under 20 CVs (400 
ml). The column was then washed out with 4 CVs of 100% ElB (500 mM 
Na2SO4). Protein fractions were concentrated using a Vivaspin 20 spin 
concentrator (3000 MCWO, Sartorius) and tested for ATPase activity using the 
malachite green phosphate assay (Section 2.2.6.3). All positive fractions were then 
pooled.   
 
2.5.4 PEG 6000 Precipitation 
PEG 6000 precipitation of solubilized TF1Fo ATP synthase was adapted from 
Ferguson et al27. Briefly, a stock solution of 50% PEG 6000 (BioRad) in SPB 
buffer was added to n-Dodecyl Maltoside solubilized protein sample to a final 
concentration of between 5% - 25%. The solution was incubated at room 
temperature with shaking for 10 mins, and then centrifuged at 20,000 g for 15 
mins, 4 oC. Aliquots are taken from the supernatant at each step, and PEG 6000 
was added again to the next percentage step. Incubation and centrifugation is then 
repeated for each percentage precipitation. The ATPase activity of the aliquots are 
then assayed using the Malachite Green phosphate assay. 
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2.5.5 Measurement of Specific ATPase Activity 
The specific ATPase activity of the protein defined as the amount of ATP 
hydrolyzed produced per unit time per unit mass of ATPase, usually expressed in 
terms of µmolmg-1s-1. ATP hydrolysis was assayed by incubating the protein 
solution with ATP for a defined period of time and detecting the free 
orthophosphate formed when ATP is hydrolyzed to ADP. A malachite green 
phosphate assay kit (BioChain) was used to detect the phosphate concentration.  
Protein sample was added to a solution containing a final concentration of 12.5 
mM MgCl and 0.25 mM freshly prepared ATP in 200 ml, and heated for exactly 
10 mins at 50 oC. The solution was then quenched by 50 µl of Malachite Green 
Reagent (MGR) and left to incubate at room temperature for 20 mins. Absorbance 
of the sample was read at 620 nm. 
 
In an adaptation of the standard protocol, the protein sample incubated with a 
higher concentration of ATP (2 – 0.5 mM) at a lower sample volume of 25 µl, 
before addition of the MGR and buffer solution to a final volume of 125 µl.  The 
rationale for this was to increase the exposure of ATP to the ATP synthase protein 
and hence increase the ATPase activity signal. MGR has a tendency to hydrolyse 
ATP to ADP due to its acidity.  This adaptation ensures a more concentrated ATP 
during hydrolysis by the enzyme, while ensuring that ATP concentration during 
the MGR colour development phase is low.  
 
2.5.6 F1Fo ATPase Inhibition Assay 
The reagent dicyclohexylcarbodiimide (DCCD) has been shown to inhibit the 
ATPase activity of F1Fo ATP synthase by binding onto the Fo sector and 
interfering with the catalytic action of the F1 sector
28. Free F1 ATP synthase is not 
 26 
affected. The enzyme integrity of the F1 and Fo units of the ATP synthase was 
assayed by preincubating the protein in 50 µM of DCCD (solubilized in ethanol) 
for 5 minutes prior to the ATPase assay.  
 
2.6 SDS PAGE 
The Laemmli method of SDS PAGE was used to stain and separate the proteins in 
order to identify the protein of interest using a Mini-Protean gel electrophoresis 
system (BioRad). Membrane-protein containing solutions were incubated in a 
denaturing sample buffer (2% SDS, 2 mM DTT, 4% Glycerol, 0.01% w/v 
Bromophenol blue) at 37 oC for 30 mins and then loaded onto a 0.75 mm Tris-HCl 
polyacrylamide gel (3% Stacking, 15% separating). Samples were run through the 
stacking layer at 100 V and separating layer at 200 V. Protein bands were 
visualized via Coomassie Blue staining (0.1% Coomasie Blue, 50% Methanol, 
10% Glacial Acetic Acid) and compared against a standard protein ladder 




2.7 Protein Quantitation Assays 
2.7.1 Lowry-Peterson Method: 
Total protein concentration was estimated using the Lowry-Peterson method for 
membrane proteins (Sigma Aldrich TP0300).  The protocol was modified by 
reducing the recommended volumes to a quarter of the original, to account for the 
lesser volume usage when using a 96-well plate instead of a cuvette.  To 250  µl of 
the protein sample, 250  µl of Lowry Reagent solution was added. The sample was 
incubated at room temperature for 20 minutes before adding 125 µl of Folin & 
 27 
Cicalteu’s Phenol Reagent Working solution. The colour is allowed to develop for 
30 mins. 250 µl of the final sample was transferred to a transparent 96-well flat-
bottomed plate. Absorbance was read at 780 nm. A bovine serum albumin (BSA) 
standard was used. 
 
2.7.2 Biocinchoninic Acid (BCA) Protein Assay: 
Total protein concentration of BR was also assayed using a bicinchoninic acid 
(BCA) protein assay (Pierce) on the PM sample. The standard protocol was 
modified by solubilizing the BSA standard and BR sample in 5% SDS solution. 
25 µl of each BR sample was added to 200 µl of the BCA kit working reagent in a 
96-well microplate, and incubated at 37 oC for 30 minutes before cooling to room 
temperature. Absorbance reading was taken at 562 nm. Bovine Serum Albumin 
(BSA) solubilised in 5% w/v SDS was used as the protein standard.  
 
2.7.3 Photometric 280 nm Absorption 
Absorption of the BR sample at 280 nm was measured using a N-1000 nanodrop 
spectrophotometer (Thermo-Scientific). 2 µl of PM working solutions was used 
for the assay, and the absorption OD was read at 280 nm, using commercially 
purchased BR (Sigma) as a standard. The standard was reconstituted at 4 mg/ml 
and serially diluted. A standard curve profile was obtained by correlating the 
known concentration to the absorbance optical density at 280 nm.  BR samples of 
varying concentrations were prepared similarly from the BR stock solution and 









Chapter 3: Results and Discussion 
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3.1 Results and Discussion 
 3.1.1 H. Salinarum S9 Culture 
Fig. 4 shows the growth curve of H. Salinarum S9, and the synthesis of the purple 
membrane. Growth was followed with a spectrophotometer by measuring the 
optical density of the cell culture at 660 nm. Synthesis of the purple membrane 
was assessed by followed by following its absorbance OD at 570 nm. Under the 
standardized culture conditions described above (Materials and Methods – 2.2.1.1), 
H. Salinarum S9 was observed to reach the end of its exponential growth phase 
between days 6 and 7. While Oesterhelt et el reported25 a sharp increase in PM 
synthesis only towards the end of the exponential growth phase, under my culture 
conditions OD 570 nm was gradual and mirrored the OD 660 nm growth 
characteristics.  This difference might be due primarily to the different strain of 
archaebacteria used. While Oesterhelt et al describes the culture of H. Halobium 
R1 (a gas-vacuoleless mutant), the strain S9 is known PM overproducer29. Also, 
differences in culture conditions such as lighting and O2 tension might account for 
the different PM synthesis profiles. Nonetheless, in order to obtain the optimal 
yield of PM the 570 nm/660 nm ratio was plotted (Fig. 5) and the cells were 
harvested at the highest point (Day 6). 
 
3.1.2 Purification of Purple Membrane 
Harvested cells were lysed and purified as detailed in Materials and Methods 
section 2.2.1.2. Fig. 6 shows the absorbance spectra of the purified PM solution, 
indicating a broad spectrum absorbance in the visible wavelengths (470 nm -720 
nm) and peak absorbance at 570 nm. This agrees closely with various published 


















Fig. 4: Halobacterium Salinarum growth profile, as measured by absorption spectroscopy at 






















































Fig. 6: Absorbance spectra of purified purple membrane. The graph shows a peak 




Fig. 7: SDS PAGE of purified BR. Lane 1 – Negative control. Lanes 2 and 5 - Protein 
markers (Precision Plus, BioRad). Lane 3 - Purified PM sample.  Lanes 4 – BR (Sigma). 
Lane 6 – BSA positive control.  
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(Fig. 7 - Lane 3). A single band between 20-25 kDa was observed, corresponding 
to that of the BR protein (~26 kDa). The size discrepancy between BR’s actual 
size and that indicated by gel electrophoresis is a known issue with BR31 and 
common among integral membrane proteins with a larger proportion of 
hydrophobic residues32. SDS PAGE migration of the membrane protein is 
influenced by the loading of SDS at its hydrophobic sites as well as final charged 
conformation. This is further confirmed by comparison with a BR standard (Fig. 7 
- Lane 4), which shows a band of identically size. Taken together, it was 
concluded that after purification, a pure protein corresponding to the BR protein in 
size and absorption spectra was obtained. In later purifications, the sucrose 
gradient ultracentrifugation step was eliminated as no other membrane bands were 
observed besides BR. This is further confirmed by the information that 
Halobacterium Salinarum S9 lacks the C-50 Carotenoids (bacterioruberins)29.  
 
 
3.1.3 BR Protein Quantitation 
In order to accurately determine the total protein concentration of the purified BR 
sample, several different quantitation methods were used, with varying levels of 
success. Due to the variability in the execution of the purification steps, the final 
BR stock concentration obtained was often different. A recurring issue with the 
protein quantitation of BR was that when different dilution factors of the original 
protein sample were assayed, the results did not agree well when used to calculate 





3.1.3.1 Lowry-Peterson Method 
Using a BSA standard (Fig. 8) and the micro-Lowry-Peterson method (Fig. 9) it 
was found that the more dilute the working protein sample used in the assay (Fig. 
9), led to a higher calculation of the protein stock solution. In order to arrive at a 
good estimate of the total protein concentration, it was decided that average of 
samples S1 to S5 would be used. Protein concentration of the BR stock solution 
(BR #1) was calculated to be 510 ± 80 µg/ml.   
 
However, reproducibility issues were encountered with the Lowry-Peterson assay 
due to the protein precipitation step with trichloroacetic acid. Protein precipitation 
was performed on the purified BR samples (BR#1) as sucrose from the sucrose 
gradient ultracentrifugation step is a known interefering agent in the assay.  The 
Peterson modification of the Lowry-Peterson assay calls includes precipitation of 
the proteins in the sample using TCA, followed by blotting of the supernatant and 
resolubilisation in the assay buffer. Samples were often lost as the quantities of 
protein precipitates were often so low they could not be observed. Precipitated 
proteins also had difficulty resolubilising, even with SDS included in the Lowry 
reagent.  Also, the protocol requires the Folin phenol reagent to be added to each 
tube precisely at the 10th minute of incubation, while simultaneously stirring each 
tube. The cumbersome procedure also limits the total number of samples that can 
be assayed in a single run. In light of these difficulties, the Biochoninic Acid assay 














Fig. 8: BSA standard curve, using the Lowry-Peterson protein quantitation method. A 
relatively good fit is obtained by using a 2
nd
 order polynomial regression, with an R
2











Fig. 9: Estimation of BR protein concentration of BR#1. Samples  were prepared respectively 
as a 0.4, 0.2, 0.1, 0.05, 0.025, 0.0125, 0.00625 dilution from stock solution and assayed via the 
Lowry Peterson method. Stock protein concentration was calculated from the dilution factor. 
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3.1.3.2 Biochoninic Acid (BCA) Protein Assay 
The BCA protein assay was evaluated as an alternative method to address these 
issues, as it is not sensitive to sucrose (< 40% w/v) or SDS (<5% w/v).  An array 
of different dilutions of two stock BR samples, one having undergone a sucrose-
gradient ultracentrifugation purification step (BR #1) and one not (BR #2), were 
solubilised in 5% SDS and assayed. 5% SDS was also added to the BSA standards, 
which were then used to generate a standard calibration curve of protein 
concentration (Fig.10).  Stock solution concentration was back-calculated from 
the dilution factors and presented in Fig. 11. Average protein concentration was 
calculated to be 440 ± 70 µg/ml for BR #1 and 4000 ± 1000 µg/ml for BR #2.   
 
The use of the BCA method eliminated the problem of sucrose contamination and 
the need for protein precipitation, and the calculated concentration of BR #1 
closely agrees with that using the Lowry-Peterson method. However, precision 
was noticeably poorer with a higher standard deviation, especially for estimations 
of BR#2. Analysis of Fig. 11 data points 1a, 1b, 1c, 2a, 2b, and 2c, show 
increasing calculated concentration with a higher dilution factor. The BSA 
standard used to generate a standard curve shows excellent scaling with dilution 
(Fig. 10.), with an R2 value of 0.999 for a 2nd order polynomial curve fit. Hence, 
one plausible reason for the discrepancy of the calculated BR concentration values 
is that the BR-OD concentration curve profile deviates from the BSA standard 
curve, owing to the differences between the soluble BSA and the hydrophobic 
membrane protein BR.  Also, the BCA assay has a disadvantage in that it does not 
have a definite colour-development end-point. As such, error is unavoidably 










Fig. 10: BSA standard curve, using BSA solubilized 5% w/v SDS, for BCA protein 














Fig. 11: Protein quantitation of BR stock solution using BCA protein quantitation method. 
Samples 1a-1e were prepared from BR stock solutions at different dilution factors (2/5, 1/5, 
1/10, 1/30 and 1/59 respectively). Samples 2a-2e were prepared at dilution factors (1/5, 1/10, 
1/30, 1/59 and 1/117 respectively). Stock BR concentration was calculated from the dilution 
factors. Results shown here represent protein concentration of the BR stock solution as 
calculated from the different dilutions.  
 








































for larger sample quantities, due to the time difference between the preparation of 
the first and the last sample, and the discrepancy between sample preparation time 
and read-time of the individual sample wells in a 96-well plate. While this effect 
might also have contributed to the variability of the calculated BR concentrations, 
it was not pursued further. 
 
3.1.3.3 Absorption A280 nm and A570 nm 
To investigate the issue regarding the incompatibility of using BSA as a standard 
for the determination of BR protein concentration, I decided to use BR purchased 
from Sigma as a standard. However, due to the prohibitive cost of the BR, it was 
not practical for use with either the Lowry-Peterson or BCA assay, where a 
relatively high volume and protein concentration is required. Instead, a BR 
standard curve was generated from absorbance at 280 nm (Fig. 12) and 570 nm, 
using a Nanodrop 1000 spectrophotometer which only requires 2 µl of sample. 
Initially, BR solutions and standards were prepared in ddH2O only (Table 1, Fig. 
12). However, it was observed that diluted standards did not generate a good 
standard curve (Fig. 12). R2 of the trendline was low at 0.983. Diluted samples of 
purified BR were assayed and a trend of increasing calculated concentration was 
obtained when using increasingly dilute BR samples (Fig. 13, 3a-3h). Using 3a-3g, 
the average purified BR concentration for BR#2 was calculated to be 14 ± 3 
mg/ml. The assay was repeated with BR solubilized in 5% SDS and yielded much 
more consistent results for both the standard curve (Fig. 12) and purified BR 
samples. R2 value for the SDS-solubilized BR standard curve was high at 0.9978, 
and the calculated stock concentrations of purified BR #1 and BR #2 show good 
agreement regardless of the dilution factor used. Using the SDS solubilisation  
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BR conc. mg/ml OD 280 nm Calculated BR conc. mg/ml 
4.00E+00 0.697 2.96E+00 
3.00E+00 0.586 2.49E+00 
2.00E+00 0.365 1.55E+00 
1.50E+00 0.229 9.74E-01 
1.00E+00 0.189 8.04E-01 
5.00E-01 0.093 3.95E-01 
2.50E-02 0.069 2.93E-01 
1.25E-01 0.031 1.32E-01 
Table 1: Calculation of BR concentration based upon BR molar extinction coefficient at 280 
nm, compared against dilution samples of BR protein standard. BR was diluted in dd H2O 
and assayed via nanodrop 1000 using 2 µl of test sample.   
 
y = 10.952x - 0.1593
R2 = 0.9978


































bR std 5% SDS
bR Std w/o SDS
 
Fig. 12: BR standard curve from absorption at 280 nm. 2 sets of a commercial BR 
preparation (Sigma) were prepared with () and without () solubilisation in 5% w/v SDS.  
































Fig. 13: Protein quantitation of BR stock solutions using A280 nm method. Samples BR#1a-
1f were prepared from stock solutions at different dilution factors (1/2, 1/3, 1/4, 1/5, 1/6 and 
1/7 respectively). Samples BR#2a-2f were prepared at dilution factors (1/3, 1/4, 1/9, 1/11, 1/13 
and 1/15 respectively). Samples BR#2 w/o SDS a-h were prepared at dilution factors (1, 3/4, 
1/2, 3/8, 1/4, 1/8, 1/16, 1/32).  Stock BR concentration was calculated from the dilution factors. 
Results shown here represent protein concentration of the BR stock solution as calculated 















method, the average protein concentration purified BR (Fig. 13) was calculated to 
be 1.6 ± 0.1 mg/ml for BR#1 and 14 ± 1 mg/ml for BR#2.  
 
Purified BR concentration was also quantitated by measuring the absorbance of 
non-solubilised BR samples and standards at 570 nm. Concentration was 
calculated to be 14 ± 2 mg/ml for BR #2. The absorbance of SDS-solubilized BR 
at 570 nm could not be measured as the denaturation of the protein causes retinal 
dissociation from the protein and loss of absorption at 570 nm. 
 
Some issues regarding the A280 protein quantitation assay need to be addressed. 
Accuracy of the assay was assessed by calculating the concentration of the BR 
protein standards using the Beer-Lambert Law based on its absorption at 280 nm, 
the molar extinction coefficient of BR at 280 nm εBR, its molecular weight MrBR, 
and the pathlength of the Nanodrop spectrophotometer L in cm. Concentration C 
[mg/ml] is calculated as follows: 
C = (A280nm/εBR.L) x MrBR 
Where εBR is that molar extinction coefficient of BR at 280 nm at 65,000 L.mol
-
1.cm-1, L is the pathlength of the Nanodrop spectrophotometer at 0.1 cm, and MrBR 
is the molecular weight of BR at 26,784 g/mol.  
 
Calculated values are tabulated in Table 1 alongside the experimental value, 
which is based on the serial dilution of a 4 mg/ml BR standard. It is observed that 
for the 4 ml/ml BR standard, the theoretical value calculated was 2.96 mg/ml. This 
lends confidence to the validity of the quantitation assay via the Nanodrop 1000, 
as the results agreed with each other to within the same order of magnitude. The 
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exact differences between calculated and experimental value can be explained by 
factors such as incomplete PM solubilisation in H2O, or machine specific errors 
introduced by the use of the Nanodrop 1000, such as the shorter path length (0.1 
cm) and lower volume used (2 µl). 
 
Nucleic acids absorb strongly in the 260 nm wavelength and contaminants in 
protein samples often interfere with A280nm readings. Using an A260/A280 ratio, the 
relative purity of a protein preparation can be estimated. The A260/A280 of purified 
BR was measured to be 0.88, comparable to that of the BR standard used (0.92). 
This indicates low nucleic acid contamination of less than 5% (Fig. 14). BR 
optical purity (A280/A570) was high at ~1.8.  
 
Fig. 14: A260/A280 ratio estimation of protein purity. (Source: 
http://www.biotek.com/resources/articles/nucleic-acid-purity-a260a280.html) 
 
Solubilisation of the BR in SDS gave a more consistent standard curve (Fig. 12) 
and greater reproducibility and precision at different protein dilutions (Fig. 13 – 
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BR#2). Calculation of the theoretical protein concentration using the A280 of 
solubilised BR gave erroneous results (not shown), but that was expected as the 
denatured BR exhibits different absorption characteristics to non-solubilised BR. 
However, it is assumed that the A280 of SDS-solubilised BR samples would follow 
closely the absorption characteristics of the similarly solubilised BR standards. A 
comparison of protein concentrations calculated from SDS-solubilised BR #2 (14 
± 1 mg/ml) and non-solubilised BR #2 (14  ± 3 mg/ml) shows great agreement, 
and suggests that SDS in itself does not distort protein concentration results when 
used with appropriate standards under similar conditions.  
 
A more troubling problem however, is the large discrepency in protein 
concentration estimated using the A280, Lowry-Peterson and BCA methods.  
Protein concentration estimates of BR#1 for the 3 methods were 1.6 ± 0.1 mg/ml, 
510 ± 80 µg/ml and 440 ± 70 µg/ml respectively. Additionally, protein 
concentration of BR#2 via A280 and BCA assay was 14 ± 1 mg/ml and 4 ± 1 
mg/ml respectively.  
 
Discrepancies between different protein quantitation assays are common 
especially when comparing methods based on different biochemical processes. 
The Lowry and BCA assays are based on the well-established biuret reaction, 
where polypeptides containing three or more amino acid residues are able to form 
a blue-violet colored chelate complex with Cu2+ ions in an alkaline environment 
containing sodium potassium tartrate. The Lowry and BCA assays further enhance 
the sensitivity of the assay by coupling a second reagent to the resulting Cu+ ion 
that results in a more intense colour. In contrast, protein absorbance at 280 nm 
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depends upon the aromatic amino acid content (tyrosine and tryptophan) in the 
protein, and to a smaller extent phenylalanine and the number of disulphide bonds.  
In all three assays, protein-to-protein variation further affects the signal and 
absorbance profile of the assay. The amino acids cysteine, tyrosine and tryptophan 
enhance Cu2+ reduction in the sample independently of the biuret reaction, leading 
to slight differences in colour development in the BCA assay in different proteins. 
In Lowry assays, the presence of any of five amino acid residues (tyrosine, 
tryptophan, cysteine, histidine and asparagine) in the peptide or protein backbone 
further enhances the amount of color produced because they contribute additional 
reducing equivalents to further reduce the phosphomolybdic/phosphotungstic acid 
(Folin-phenol reagent) complex.  
 
Hence, it is hypothesized that for the Lowry and BCA assay, the use of BSA 
(which differs from BR in size, shape, hydrophobicity and amino acid content) as 
a standard was the main reason why the estimated BR concentration differed so 
greatly from the A280nm method.  
 
It was decided that despite the discrepancies between the quantitation methods, 
the protein concentration estimated using A280nm method would be used. The 
decision is supported by several factors:  
• BR protein standard was used instead of BSA 
• Good reproducibility and precision at different protein concentrations 
• Calculations using BR chromophore absorbance at A570nm correlates well 
with that using A280nm.  
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3.1.4 Pyranine Optimization 
Pyranine (8-Hydroxypyrene-1,3,6-trisulfonic acid, Sigma) is a pH-sensitive 
fluorescent dye whose emission at 516 nm decreases as a function of pH when 
excitation is at 405 nm and increases when at 450 nm (Fig. 15). By plotting the 
ratio of fluorescence emission (450 nm/405 nm) as a function of pH, we can 
determine the pH of a sample independent of pyranine concentration. This assay 
allows pyranine encapsulated within BR-liposomes to report the lumen pH change 
due to the inward proton-pumping activity of BR.  
 
As slight variations in the peak excitation wavelengths have been reported33,34,35 in 
various literature, pyranine reagent was assayed under acidic, basic and neutral pH 
conditions by performing an excitation wavelength spectrum scan at a fixed 
emission wavelength of 516 nm. Fig. 15 shows maximal fluorescence change at 
405 nm and 450 nm with changing pH. A pH-independent isobestic point at 
excitation wavelength of 415 nm is also observed.  
 
The ratiometric fluorescence technique is a well-established technique with 
unique advantages. Single fluorescence emission is influenced by a variety of 
factors such as the geometric factor, quantum yield, extinction coefficient and 
concentration of the flurorescent probe. The detector introduces variables such as 
excitation intensity, optical pathlength and its quantum efficiency, while in a 
sample, uneven loading or compartmentalization of the probe influences the 
fluorescence emission36. Fluorescence ratio measurements from dual wavelength 
fluorophores are theoretically independent of dye concentration37, making it 
perfect for use in intra-liposomal reporting of pH changes in BR-liposomes, where  
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Fig. 15: Excitation spectrum of pyranine fluorescence at acidic (triangles), basic (square) and 
neutral (diamond) pH of 7.20, at emission wavelength of 516 nm.  Fluorescence is observed to 
decrease with increasing pH at 405 nm, and increase with increasing pH at 450 nm. A pH 











Fig. 16: F450/F415 and F450/F405 fluorescence ratio as a function of log-pyranine 
concentration. F450/F405 ratio is observed to increase sharply at pyranine concentration 








































batch-to-batch variation makes it difficult to fix the amount of dye encapsulated.   
F450/F405 ratiometric fluorescence has been successfully reported to track 
intracellular pH changes in cells37 as well as BR-liposomes34. As the two 
excitation peaks vary with pH in opposite directions, taking a F450/405 
fluorescence ratio confers greater than 50-fold sensitivity between the most acidic 
and basic physiological pH found in cells. 
 
However, the results obtained in these experiments of pyranine fluorescence ratio 
and concentration show that concentration does affect the F450/F405 ratio. Fig. 16 
shows that in a 20 mM PIPES buffer at pH 7.2, the ratio remains somewhat 
constant at ~0.75 for pyranine concentrations below 100 µM, it is no longer 
constant and rises with increasing concentration above 100 µM. This has serious 
implications as it means that at high encapsulation concentrations of pyranine, 
fluorescence ratio is concentration dependent and the reported pH of liposomes 
with different dye loadings cannot be compared with each other.   
 
As an alternative, the fluorescence ratio of F450/F415 was evaluated, where 
excitation at F450 indicates the level of pyranine ionization, and F415 at the pH 
insensitive isobestic point is a measure of only pyranine concentration (Fig. 16). It 
was found that the fluorescence ratio stayed constant ~1 for a larger range of 
pyranine concentrations, up to 1 mM. A pH standard curve was then generated 
against the F450/F415 ratio (Fig. 17) by preparing a series of 100 µM pyranine 

























Fig. 18:  Normalised log-fluorescence RFU of 100 µM pyranine with increasing DPX 











































The resulting curve is well fit by a 3rd order polynomial: 
[pH] = 0.5762x3 - 2.0371x2 + 3.0117x + 5.6293 
where x refers to the F450/F415 ratio. 
 
In preparations of pyranine-encapsulated liposomes, pyranine is initially present in 
equal concentrations both inside the liposome and in the bulk solution of the 
sample. In order to track the pH inside the liposome, external pyranine has to be 
quenched so that all fluorescence changes originate only from the lumen. This can 
be achieved either by dialysis of the liposome sample, or by using DPX, a 
membrane-impermeable cationic fluorescence quencher.  
 
100 µM pyranine solution was titrated against DPX and the relative quenching of 
pyranine fluorescence was measured (Fig. 18). It was found that fluorescence 
quenching approached a minimum of 0.1 % fluorescence at 30 mM DPX or more. 
However, an interesting phenomenon was observed where the F450/F415 ratio 
was observed to dip at 10 mM of DPX added, and then gradually returning back to 
its original ratio at 50 mM DPX and above (Fig. 19). This phenomenon was 
observed reproducibly at different concentrations of pyranine (not shown). One 
possible reason could be that DPX interaction with pyranine caused a change in 
the pKa of its ionized forms and hence changed its fluorescence profile. Cations 
have been reported to cause artifacts in their interaction with pyranine35. However, 
this phenomenon was not pursued further as it was outside the scope of the project. 
Although it was found that 30 mM of DPX was sufficient to quench 100 µM of 
pyranine by ~99.9%, the deviation in fluorescence ratio at lower DPX 






















Fig. 20: Quenching assay for liposomes encapsulated with pyranine. The chart shows the 
Log-RFU (415 nm) of pyranine before and after quenching with DPX.  Column 1 shows the 
RFU of 2 mM pyranine (formulated to match the raw fluorescence RFU intensity of 
pyranine-encapsulated liposomes) before and after quenching with an excess (106 mM) of 
DPX. Column 2 shows the fluorescence quenching of liposomes without encapsulated 
pyranine in the same 2 mM pyranine control solution. Column 3 and column 4 show the 




















Fig. 19: F450/F415 and F450/F405 fluorescence ratio of pyranine with increasing DPX 
concentration.  
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involving the quenching of pyranine in liposome solutions would utilize at least 
50 mM of DPX.  
 
3.1.5 Encapsulation of Pyranine in Liposomes  
The encapsulation of pyranine inside liposomes had to be optimized empirically to 
solve the following issues: Loading concentration of the fluorophore during 
liposome synthesis had to be high, as subsequent dialysis of the liposome samples 
yielded samples with much lower raw fluorescence values. The dialysis process 
also compounded the problem of slight fluorophore leakage over 24 hours.  
 
In the first proof of concept of pyranine encapsulation within liposomes, an excess 
amount of 4 mM pyranine was loaded into the liposomes. Fig. 20 demonstrates a 
successful encapsulation of pyranine within liposomes and BR-liposomes. 
Pyranine concentration was measured via fluorescence at excitation 415 nm. The 
synthesis of the liposomes and BR-liposomes follows that of Rigaud et al38,39 and 
are described above in Materials and Methods (Section 2.2.3). The results 
(columns 5, 7) show that pyranine was successfully encapsulated at high signal 
intensity inside liposomes and BR-liposomes. Even after quenching with 106 mM 
of DPX (in excess), residual fluorescence remained high at 67% for liposomes and 
62% for BR-liposomes. In contrast, an equivalent amount of free pyranine (2 mM) 
in buffer (columns 1,2) had a residual fluorescence of 0.05 % after the same DPX 
treatment. As an added control, a sample of liposomes without encapsulated 
pyranine was also prepared, and 2 mM of the fluorophore added externally into 
the sample. Upon DPX quenching, residual fluorescence was 0.15 %, further 
confirming the efficacy of the pyranine encapsulation protocol. 
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3.1.6 Incorporation of BR into Liposomes 
In order to achieve unidirectional pumping of H+ ions into the interior of the 
liposome, BR has to be uniformly oriented in the liposome membrane, with the 
hydrophilic carboxylic tail of BR oriented facing outwards. This is achieved by 
the integration of BR externally into preformed, detergent-destabilized liposomes. 
In contrast, BR-liposomes synthesized that were reformed from protein-
phospholipid-detergent mixed micelles via detergent removal have reportedly 
lower inward H+ pumping capacity due to the more random orientation of the BR 
in the phospholipids membrane40,41.  
 
The solubilization process of liposomes via detergent can be described with a 
three-stage model progressing with increasing detergent concentration. Stage I, 
where non-micellar detergent integrates into the liposomal bilayers; Stage II, 
where liposomes start to solubilize and lipid-detergent mixed micelles co-exist 
with detergent-saturated lipid bilayers; and Stage III, characterized by complete 
solubilization of all the lipids. The stages can be visualized optically using a 
spectrophotometer by tracking the solution turbidity at 660 nm upon addition of 
detergent. Turbidity of the liposome solutions increases during Stage I, followed 
by a drop in turbidity in Stage II leading to an optically clear solution by the onset 
of stage III. By plotting the phospholipid concentration against the detergent 
concentration required to bring about the end of Stage I and the onset of Stage II, 
a relationship between phospholipid concentration and the detergent concentration 
required to saturate the phospholipids membranes can be described: 
[Detergent] = Dw + R
sat.[Phospholipids]   (2) 
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Where Rsat is a constant relating to detergent to phospholipids molar ratio for 
detergent-saturated liposomes, and Dw is the monomer detergent concentration in 
equilibrium with the liposomes. Dw and R
sat are specific for the type of detergent 
as well as phospholipids.  
 
In our experiments, the non-ionic Octyl glucoside (OG) was the detergent of 
choice, as it was reported to achieve highly oriented BR directionality in 
liposomes and excellent inward-directed proton pumping activity when BR was 
incorporated into OG-saturated liposomes40. Furthermore, BR monomers 
solubilized in OG are stable and retain their functional properties. Lastly, its high 
critical micelle concentration allows for more rapid detergent removal and makes 
it easier for liposome reconstitution. R sat and Dw values for OG are 1.3 and 17 
mM respectively40, for concentration values expressed in mM. Phospholipid to BR 
ratio was fixed at ~35:1 w/w, as it was reported to achieve the highest pH change 




 Pumping Activity Assay 
Initially, BR-liposomes were synthesized with a starting 4 mM of pyranine and 
then dialyzed to remove external pyranine after reconstitution. Fig. 21 shows the 
change in pH within the BR-liposomes under illumination with light. Liposomes 
incorporated with purified BR as well as the BR standard (c-BR) both demonstrate 
a significant drop in pH with illumination time. Liposome and pyranine controls 
show no appreciable pH changes. However, it was found that the dialysis step to 
remove external pyranine led to low fluorescence signals. After several days, 












Fig. 21: pH change with time inside the lumen of BR-liposomes under light illumination. 0.8 
mM of pyranine was encapsulated in 20 mM of liposomes without BR (), 0.5 mg/ml of 
purified BR () and 0.5mg/ml of commercially purchased BR from Sigma(-). 100 mM of 
DPX was used to quench external residual pyranine in solution before light illumination. 500 











Fig. 22: DPX quenching assay for BR-liposomes.  The chart shows the relative fluorescence 
decrease in pyranine fluorescence for up to 2 mins after addition of 100 mM DPX. From left 
-Column set 1 (500 µM Pyranine control) shows that 500 µM pyranine in free solution 
experiences a fluorescence decrease to 0.34% after addition of DPX.   Column set 2 (20 mM 
liposomes w/ 0.8 mM pyranine) experiences a significantly higher residual fluorescence (18%) 
after DPX addition. Column sets 3 and 4, denoting BR#1 and BR#2 liposomes respectively, 
experiences a lower but still significant residual fluorescence of 2.62% and 6.08%. 



































pre-DPX 100 100 100 100
post-DPX 0.34 17.98 2.62 6.08
+1 min 0.33 17.88 2.13 5.74
+2 min 0.34 18.00 2.02 5.69
500uM Pyranine 
control
Liposome #1 bR-Liposome #2 bR-liposome
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quenching prior to the illumination assay, indicating that there was some 
fluorophore leakage into the medium (Appendix: Fig. 34).  
 
In order to prevent this, it was decided that the dialysis step could be eliminated. 
A 2nd experiment was repeated using BR#1 and BR#2 samples. After synthesis, 
samples were kept in the dark at equal pyranine concentrations inside and outside 
the liposome. The external pyranine was only quenched with 100 mM DPX 
immediately prior to light illumination assay (Fig. 22). Due to the higher 
component of external pyranine in the sample, the liposome and BR-liposome 
samples experienced a much larger fluorescence drop upon addition of DPX. Post-
quenching fluorescence of liposomes was between 2.62% and 18%, with both BR-
liposome samples showing slightly lower residual fluorescence than the liposome 
control. However, this was still significantly higher than that of free pyranine 
control, which was quenched to 0.034%. Residual fluorescence was monitored for 
up to 2 minutes to ensure that the quenching process was complete. While the free 
pyranine and liposome samples show stable signals over 2 minutes, BR-liposomes 
were observed to exhibit minute, gradual decreases in pyranine fluorescence over 
time. It is hypothesized that the insertion of BR into the bilayer membrane might 
have slightly destabilized the liposome and caused some leakage. However, the 
light illumination assay (Fig. 23) shows clear H+ pumping activity by the BR-
liposomes, indicating that the dialysis step to remove external pyranine is not 














Fig. 23: pH change with time inside the lumen of BR-liposomes under light illumination. BR-
liposomes were synthesized without dialysis after pyranine encapsulation. External pyranine 
fluorescence was minimized solely through quenching by DPX prior to light illumination.  
0.8 mM of pyranine was encapsulated in lipsome samples. Two different synthesis batches of 
BR ( - BR#1,  - BR#2) were incorporated into 20 mM liposomes at 0.5 mg/ml.  Lipsome 












Fig. 24: Bacillus PS3 growth profile, measured at 660 nm absorption. Bacillus PS3 is 
observed to display a quiescent initial growth phase followed by a sudden increase at around 










































Several important conclusions can be drawn from this series of results. Firstly, 
that the functional proton-pumping activity of BR was retained even after the 
purification process, and closely matched that of commercially obtained BR. 
Secondly, it was proof of concept that the protocol enabled the synthesis of BR-
liposomes that showed clear, significant H+ pumping activity. This indicates that 
the integrated BR proteins were mostly oriented uniformly and in an ‘inside out’ 
configuration. Thirdly, that the experimental design allowed the sensitive 
reporting of pH changes inside BR-liposomes using pyranine.  
 
 
3.1.8 Bacillus PS3 Culture 
Thermophilic F1F0 ATP synthase (TF1F0), harvested from the hot-spring residing 
bacteria Bacillus PS3, has been found to be extremely stable, even at temperatures 
up to 75 °C23. Culture of Bacillus PS3 is relatively straightforward, as described in 
Section 2.2.6.1. The high temperature of 65 oC for culture required a few 
adaptations from standard bacterial culture protocol. Bacterial colonies on agar 
had to be grown at a reduced temperature of 55 oC to prevent agar from melting. 
The upturned Petri dishes had to be sealed tight with parafilm to prevent excessive 
evaporation and drying of the agar. The bacterial growth in culture media exhibits 
a quiescent phase for approximately 3.5 hours followed by a rapid growth phase 
peaking at 5 hours and an equally rapid drop after that (Fig. 24). Cells were 
harvested at or near the peak of the growth phase.  
 
3.1.9 DEAE Anion-Exchange Chromatography 
DEAE anion exchange chromatography has been the preferred choice for 
purification of the TF1F0 ATP synthase protein
26,42-44, but it has proven 
 58 
challenging to replicate successfully. Protein elution could not be tracked via UV 
detection at 280 nm, as p-aminobenzamidine, a serine protease inhibitor used in 
the sample buffer, absorbs in the UV region. Hence, the presence of TF1F0 ATP 
synthase could only be detected at the end of the IEX process by testing each 
eluted fraction for ATPase activity (Fig. 25). 
 
Based on the results, 2 peaks of ATPase activity were identified, the first between 
fractions 12-18 and the second between fractions 19-35. Following protocols from 
Montemagno’s group (personal communications), ATP synthase was expected to 
be eluted between 190-390 mM of Na2SO4 elution buffer. In my own experiment 
run, fractions 12-18 and 19-35 correspond to 41 – 113 mM and 113 – 287 mM 
respectively. Both sets were pooled into two separate samples and concentrated 
further using a Vivaspin 20 3000 MCWO centrifugal concentrator.  
 
3.1.10 SDS PAGE Analysis 
SDS PAGE was performed on the membrane proteins at each stage of the 
purification process. Fig. 26 focuses on the pre-IEX processes such as membrane 
washing, cholate treatment and solubilization by n-dodecyl maltoside.  Fig. 27 
includes the two pooled protein fractions obtained from IEX, where protein 
sample 1 refers to the pooled fractions 12-18 and protein sample 2 is pooled 
fraction 19-35.  
 
As a confirmation of the efficacy of the purification process, it was hoped that the 




Fig. 25:  Malachite green phosphate assay of protein fractions after DEAE anion exchange 
chromatography. Concentrated eluted fractions were assayed for ATPase activity using the 
Malachite Green phosphate assay after incubation with 0.2 mM ATP at 55 
o
C for 15 mins. 
Fractions 12-18 and 19-35 show two peaks of ATPase activity relative to a baseline of OD 0.7 
and are pooled together as sample #1 and sample #2 respectively for further analysis. 
 
 
Fig. 26: SDS PAGE of TF1Fo ATP synthase purification process: Lane 1 - BSA positive 
control. Lane 3 & 9 - Protein markers. Lane 2 – Lysed Bacillus PS3 cells. Lane 4 – Wash 
supernatant. Lane 5 – Washed membranes. Lane 6 – Cholate treatment supernatant. Lane 7 
– Cholate treated membrane. Lane 8 – n-Dodecyl Maltoside-treated membrane supernatant. 





























































Fig. 27: SDS PAGE of TF1Fo ATP synthase purification process: Lane 1 - BSA positive 
control. Lane 4 & 7 - Protein markers. Lane 2 – Lysed Bacillus PS3 cells. Lane 3 – Washed 
membranes. Lane 5 – Cholate treatment membrane. Lane 6 – n-Dodecyl Maltoside treated 
membrane supernatant. Lane 8 – IEX purified protein Sample#1. Lane 9 – IEX purified 
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weights of the individual subunits (in Da) are α: 54,590; β: 51,938; γ: 31,778; a: 
23,483; δ: 19,657; b: 17,268; ε: 14,333; c: 7,335.  
 
However, an initial observation of the bands on sample #1 and #2 (Fig. 27) did not 
show protein bands of the expected sizes.  Due to the large variety of different 
proteins present, it was difficult to identify the actual subunits. However, by direct 
comparison with samples from the cell lysate, washed membranes, cholate treated 
membranes and n-dodecyl maltoside solubilized supernatant, in which the TF1F0 
ATP synthase are expected to be present, their expected locations could be 
deduced. Using the SDS PAGE image and the positions of the protein marker 
(Lane 4), a trend was tabulated relating the protein size to the vertical 
displacement in the gel. Based on this, it was possible to calculate at what the 
position within the gel the subunits were expected to be, and possible candidates 
for α, β, γ, δ, ε, a and b could be identified. Subunit c, at 7335 Da, was too small 
and not captured within the gel.  
 
All sub-units except c could be visualized up to the point of detergent 
solubilization, where sub-units a, δ and ε could not be distinguished. Some doubt 
also exists regarding whether the rest of the F1 units α, β and γ are present in the 
supernatant. The α and β bands in the n-DM solubilized sample were not as 
strongly defined as in the previous purification steps, while there is some 
uncertainty regarding the identity of γ among several other proteins in the same 
weight range.  
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Sample #1, corresponding to eluted fractions 12-18, only showed possibly α, β 
and γ subunits, while Sample #2, corresponding to fractions 19 – 35,  did not 
exhibit any possible ATP synthase subunit except γ.  
 
In order to troubleshoot further, the wash supernatants were also assayed via SDS 
PAGE (Fig. 26). Using the α and β protein bands as a reference, it can be seen 
that the first membrane wash supernatant contained significant quantities of it, 
indicating perhaps the detachment of the F1 subunit from the entire protein 
complex. This is a commonly reported occurrence26,23 and is usually attributed to 
inadequate buffer strength of Tris-sulphate. However, the 50 mM Tris-sulphate 
used in our buffer is congruent with that reported for purification of intact TF1F0 
ATP synthase.  
 
Another observation that can be made is regarding the low presence of subunit a 
in the detergent solubilized supernatant. This may indicate poor solubilisation of 
the membrane and the inability to solubilize the TF0 portion of the protein.  
 
 
3.1.11 Specific ATPase Activity Assay 
Specific ATPase activity of the protein samples at each processing stage was 
assayed. Activity was taken as the µmol quantity of phosphate liberated by the 
hydrolysis of ATP per minute, measured via malachite green phosphate assay. 
Quantitation of total protein concentration was done using the BCA method, with 
BSA as a standard.  
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Fig. 28 shows that with each successive purification step (#1 to #4), specific 
ATPase activity of the protein sample was increased. Purified protein sample 2 
(#6), corresponding to the pooled fractions (19-35) shows approximately 167-fold 
more activity than protein sample 1 (fractions 12-18), and 11.4-fold increase over 
the previous n-dodecyl maltoside purification step (#4).  
 
3.1.12 DCCD Inhibition Assay 
In order to ascertain that the F1 portion of the ATP synthase is still attached to the 
membrane-spanning F0 region, we assayed the sensitivity of the protein to DCCD. 
Previous studies have shown that DCCD binds to F0, thereby inhibiting ATPase 
activity of the connected F1. Free F1 is not inhibited by DCCD binding. Hence, 
insensitivity to DCCD implies detachment of F1 from F0. Fig. 29 shows the 
percentage inhibition of ATPase activity of the protein samples. It can be seen that 
enzyme integrity remains relatively high throughout the purification process, with 
ATPase activity being inhibited by at least 56.8% save for the directly lysed cell 
matter. DCCD sensitivity of purified protein sample 1 (Fractions 12-17) is 
observed to be higher than that of purified protein sample 2 (Fractions 18-35).  
 
3.1.13 Purification of TF1F0 ATP synthase via PEG 6000 precipitation 
A simpler, more cost-efficient method of purification via Polyethylene Glycol 
(PEG) 6000 precipitation was tested based on methods of Cook et al45. PEG are 
non-ionic polymers of ethylene oxide typically ranging in size from 200 Da to 20 
kDa. They are water soluble due to the ether oxygens which are distributed along 
the length of the polymer, acting as strong Lewis bases and forming H-bonds with 





















































































































Fig. 28: Specific ATPase activity of purified TF1Fo ATPase protein samples: #1-Lysed cells, 
#2 Washed Membranes, #3, Cholate-extracted membrane, #4 n-DM solubilised proteins, #5 





























Fig. 29: Percentage inhibition of ATPase activity of protein samples after incubation with 
DCCD. Sample 1 – Lysed Cells, 29.6%. Sample 2 – Washed Membrane, 67.6%. Sample 3 – 
Cholate-extracted membrane, 86.0%. Sample 4 – n-DM solubilised membrane supernatant, 
56.8%. Sample 5 – IEX purified sample #1 (fractions 12-17), 72.9%. Sample 6 – IEX purified 
sample #2 (fractions 18-35), 62.7%.  
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an alternative to other precipitation agents such as ammonium sulphate or TCA, 
due to its ability to protect proteins from denaturation. PEG is often preferred due 
to its low working viscosity even for concentrated solutions. In addition, the 
formation and equilibrium of precipitates takes less time than with ammonium 
sulphate. By adding PEG 6000 in sequential increasing concentrations and 
removing the precipitates at each stage, the protein sample can be fractionated 
step-wise and purified.  
 
Fig. 30 shows the relative ATPase activity of the protein sample at different PEG 
6000 concentrations. It is observed that ATPase activity begins to dip around 12% 
w/v PEG, indicating the onset of precipitation of the ATP synthase. Based on this, 
a ‘salt cut’ was performed at 12% PEG 6000. Protein precipitates were removed at 
3% PEG, 12% PEG, and finally at 30% PEG.  It is assumed that most of the ATP 
synthase would be precipitated out by 30%. The three protein samples (0-3%), (3-
12%) and (>12%) were analyzed by SDS PAGE (Fig. 31). The subunit bands α, β 
and γ were visualized strongly and clearly in Lane 2, comprising proteins 
precipitated at >12% PEG. However, there is some ambiguity regarding the 
presence of the fainter δ, ε, a and b subunits, although protein bands at the 
expected sizes are present.   
 
The specific activities of the PEG purified proteins was assayed and compared 
against the n-dodecyl maltoside solubilized sample (Fig. 32). Sample #3, 
corresponding to the protein sample precipitated between 12 % - 30%, shows a 
specific ATPase activity at 0.787 mol.mg-1.min-1, significantly higher than the 






























Fig. 30: Relative ATPase activity of PEG 6000 precipitated proteins. Aliquots of protein 
solution were taken out and assayed after every step-wise increase in PEG 6000 
concentration. The figure shows that ATPase activity remains constant in the supernatant 
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Fig. 31: SDS PAGE of PEG 6000 
precipitated proteins. Lane 1 and 5: 
Markers. Lane 2: >12% PEG-
precipitated proteins. Lane 3: 3%-
12% PEG-precipitated proteins. 
Lane 4: <3% PEG-precipitated 
proteins. 
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Fig. 33: DCCD inhibition 
assay of 12%-30% PEG-6000 
precipitated proteins. Sample 
1 - PEG-purified protein 
sample. Sample 2 – Control 
with ethanol added. Sample 3 
– Incubated with DCCD. S3 
was inhibited 62.8% 



































































Fig. 32: Specific ATPase activity 
of PEG-precipitated proteins. 
Sample #1 – 0% proteins. 
Sample #2 – 3%-12% 
precipitated proteins. Sample #3 
12-30% precipitated proteins. 
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detergent solubilized sample at 0.28. This confirms the effectiveness of PEG 
precipitation as a further purifying step. The enzyme integrity of the protein 
sample (12-30%) was determined via DCCD inhibition assay (Fig. 33). Incubation 
of the protein sample with ethanol (S2), the solvent used for DCCD, shows a 
slight activation of 25% compared to (S1). Sample incubated with DCCD (S3) 




















In this study our aim was to develop a construct utilising biomimetic principles to 
transduce light energy into ATP, a biologically compatible form of energy. By 
using the light-sensitive proton pump BR found in Halobacterium Salinarum S9 
and coupling it with TF1Fo ATP synthase from the thermophilic Bacillus PS3 in a 
lipid vesicle membrane, we hoped to demonstrate the synthesis of ATP by this 
construct under light illumination, and further demonstrate feasibility of using this 
light transduction process to power a separate biological reaction via the 
utilisation of synthesized ATP.  
 
The parameters for the culture of Halobacterium Salinarum S9 and purification of 
PM were established, and found that after 6 days in culture, 1 L of Halobacterium 
Salinarum culture yielded a purified, purple-coloured,  single-band protein of 20-
25 kDa with a maximum absorption wavelength of 570 nm corresponding to BR 
protein.  
 
Exact protein concentration of the purified sample was an issue due to the non 
correlation of results obtained by the Lowry, BCA and A280nm assay methods. 
However, it was decided that measurement by A280nm yielded the most consistent 
results due to its high reproducibility at different testing concentrations, and the 
availability of BR as a protein standard. 
 
The parameters for the observation of pH change within the lumen of a lipid 
vesicle were established. pH response of pyranine was found to be more stable at 
higher concentrations using the emission fluorescence ratio at 450/415 nm, 
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compared to 450/405 nm commonly mentioned in literature. Concentration of 
DPX required to sufficiently quench pyranine by 99.9% was established to be at 
least 50 mM. 
 
Liposomes were synthesized encapsulating a concentration of 4 mM Pyranine and 
subsequently quenched with 106 mM of DPX exhibited a high residual 
fluorescence of 67 % compared to 0.05 % for 2 mM of unencapsulated pyranine. 
BR-liposomes containing pyranine showed a significant drop of 0.4 pH in 1 hr 
upon illumination with light. 
 
The parameters for the culture of Bacillus PS3 were established, requiring 
approximately 300 minutes of culture to reach the end of log phase growth. 
Purification of intact TF1Fo ATP synthase via DEAE anion exchange 
chromatography was less than satisfactory, due to a high background and unclear 
ATPase activity signals in the eluted fractions. SDS PAGE analysis of the 
purification stages failed to reveal the expected protein subunits. The final purified 
fractions displayed specific ATPase activity of 1.87 µmol.min-1.mg-1 and showed 
only a 62.7% inhibition with DCCD, suggesting that a relatively large proportion 
of F1 subunit was detached from the Fo subunit. 
 
The method of PEG 6000 fractional purification was investigated. It was found 
that TF1Fo ATP synthase was precipitated out of PEG 6000 from approximately 
12% (w/v), with relative ATPase activity dropping to 30% at PEG 6000 
concentration of 25% (w/v). ATP synthase purified from this 12% - 30% fraction 
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was found to have a specific ATPase activity of 0.79 µmol.min-1.mg-1 and with an 
inhibition of 62.8% inhibition under DCCD incubation. 
  
4.2  Challenges Encountered  
Membrane proteins are notoriously difficult to purify, and while the protocol 
followed has been reported to successfully purify TF1Fo ATP synthase, specific 
differences in lab environment, procedures or even reagent quality mean that 
protocols do not always reproduce well from one place to another. While 
purification of the TF1F0 ATP synthase protein with DEAE ion exchange 
chromatography remains the commonly reported method for many research labs, I 
was not able to replicate it as successfully, due to the high technical difficulty of 
the process.  Hence, the PEG 6000 precipitation method was evaluated as an 
alternative method for purifying the ATP synthase as it was relatively inexpensive, 
simpler and faster.  
 
Comparing both methods, it appears that based on ATPase activity assays some 
measure of purification was achieved. Despite the inability of SDS PAGE to 
visualize all the protein subunits, the significant ATPase activity of the protein 
samples suggests that TF1Fo ATP synthase protein is present.  
 
Purification by DEAE ion-exchange chromatography yielded a protein sample 
with specific ATPase activity of 1.87 µmol.min-1.mg-1 and is 62.7% inhibited by 
DCCD. PEG 6000 purified protein achieved 0.79 µmol.min-1.mg-1 and 62.8% 
inhibition. While both are comparable to each other, they both fall short of the 41 
µmol.min-1.mg-1 and 80-95% inhibition reported in literature26.  The discrepancies 
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can have several explanations, and the most likely is that of insufficient 
purification. SDS PAGE analysis of the protein fractions show numerous 
contaminating proteins aside from the expected ATP synthase subunits, while 
comparing between treated membranes and the wash supernatants show plenty of 
protein band overlap, indicating both a loss of the proteins into the wash, as well 
as inefficient removal of unwanted proteins. Besides purity, the nature of the 
activity assay used, protein incubation temperature, as well as the protein 
quantitation method, all heavily influence the calculated specific ATPase activity 
and make it difficult to compare with other published results. 
 
4.3 Suggestions for Improvement 
On hindsight, several refinements could be made in order to achieve greater 
purification success with the TF1Fo ATP synthase protein. Firstly, washing and 
treatment of the cell membrane could be more thorough, at the expense of yield. 
By eliminating or replacing p-aminobenzamidine from the buffer solution, 280 nm 
UV could be used to track the protein elution profile, enabling a more accurate 
tracking of which fractions they elute in. If the PEG 6000 protocol is employed, 
an extra fractional precipitation with ammonium sulphate could further enhance 
purity. ATPase activity signals could be further enhanced by increasing the 
incubation temperature of the protein with ATP to 65 oC instead of 50 oC, as the 
ATPase works optimally at that temperature. However, evaporation of sample 
becomes an issue that has to be taken into account. Size-exclusion 
chromatography could be used as an extra purification step. The SDS PAGE 
procedure could be improved by using the higher-sensitivity silver stain instead of 
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Coomasie Blue to visualize hard-to-detect bands. Greater resolution of the smaller 
sized proteins can also be achieved with the use of a gradient gel.   
 
 
4.4 Directions and Outlook 
Initial attempts had been made to incorporate BR and the partially purified TF1F0 
into liposomes via the method as outlined by Rigaud et al18,19. H+ pumping 
activity was assayed via intra-lumen change of pyranine fluorescence; ATP 
synthesis activity under light illumination via a luciferin-luciferase based ATP 
detection kit.   However, positive results were not obtained as yet. In this aspect, 
more work needs to be done to improve the purification of TF1Fo ATP synthase to 
an acceptable level, fine-tuning the reconstitution protocols and adjusting the BR 
to ATP synthase ratios for optimal ATP synthesis. 
 
4.4.1 Liposome Stability 
As liposomes are metastable structures prone to aggregation and fusion46, it is 
important that the issue of its stability to mechanical and biological effects be 
addressed. Such reinforced proteoliposome architectures hold significant promise 
for biologically-based power generation and storage. Early attempts such 
stabilisation included incorporating cholesterol and negatively charged lipids into 
the lipid membrane to enhance structural rigidity and discourage fusion18.  More 
recent attempts explored methods of encapsulating liposomes in a silica sol-gel 
matrix20 or substituting phospholipids for synthetic co-polymers21.   
 
In particular, liposome encapsulation via layer-by-layer technology would be a 
worthwhile advance in project direction, taking into account its promise reported 
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in literature and available expertise on hand by Dr Dieter Trau’s Nanobioanalytics 
Lab in NUS. Ruysschaert et al47 and Ge et al48 both report the success of 
encapsulating liposomes in alternate polyelectrolyte layers using layer-by-layer 
(LbL) technology. The use of a polyelectrolyte lbl coating serves to make it more 
mechanically robust, prevent liposomal fusion and aggregations, and shield both 
the lipid as well as the membrane proteins from mechanical damage and 
enzymatic degradation. It also allows nanoscale encapsulation as opposed to the 
macroscale proteoliposome/sol-gel architecture20, and can also act as a 
mesoscopic glue49 to attach the encapsulated liposome to different functional units. 
Added functionality may also be conferred to the polymer coating50 without 
needing to incorporate changes that may compromise the integrity of the liposome 
bilayer. Layer-by-layer technology allows permeability of the polymer coating to 
be tailored51, allowing desired biosynthesized products such as ATP to pass 
through while keeping out the larger proteases. 
 
Specifically, the following could be done to pursue this direction of research: 
• Polyelectrolyte coating of the BR-ATP synthase proteoliposome with 
multi-layers of polyelectrolytes (polystyrene sulfonate and polyallylamine 
hydrochloride) using the layer-by-layer technique, and assessing its 
effectiveness as a protective barrier towards mechanical and chemical 
damage. ATP synthesis functionality under the influence of the coating 
will also be assessed. 
 
• Structural integrity of the inner liposome layer after coating will be 
examined using fluorescent dye encapsulation and testing for leakage. 
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• Proteoliposome capsules will be subjected to proteolytic activity to test 
the protective effect of the coating. 
• Permeability of the coating to the small molecules ATP and ADP will 
be monitored. 
• ATP synthesis will be monitored over a long timescale (several months) 
to evaluate long-term stability and performance. 
 
4.4.2 Synergistic Applications  
The potential uses of this ATP generation system are myriad. ATP will be an 
important fuel source for powering future nanodevices based on biomimetic 
technology. Primarily, its applications would be as power supply units for 
molecular motors as well as other high-order biosynthetic platforms.  
 
The BR/ATP synthase proteoliposome construct has great potential to play a 
crucial support role in the operation of biologically-inspired nanodevices that 
draw on ATP to function, much as a battery does for our electronic devices of 
today. Harnessing the relatively limitless power of sunlight and recycling of the 
biological energy carrier ATP/ADP enables a clean and long-term operation, 
while more advanced control over the light source, e.g. lasers, wavelength, 
intensity, focal points, enables extremely sophisticated modulation of the device 






4.4.2.1 Cell-Like Entities 
Cell-like Entities (CLE) are non-replicating proteoliposomes containing a limited 
set of introduced genes to control and perform very specific tasks3. Depending on 
the genes employed, complex phenotypes may be obtainable. CLEs rely on 
nutrient exchange with the surrounding feeding solution across the membrane via 
nanopores mediated by in-vitro transcribed-translated alpha-hemolysin, which 
facilitate small molecule diffusion but retain DNA, RNA and translated proteins in 
the liposome. An ATP regenerating system was used to continuously support 
protein synthesis for up to 3 days52. The usefulness of CLE extends towards use in 
natural environment, either as biosensors or biocatalytic enablers. However,   
CLEs to be introduced into the environment will not have a man-made feeder 
solution. In order to enable long term operation of these CLEs, the BR/ATP 
liposomes could be co-encapsulated within, acting as ATP generating organelle 
compartments within the CLE much like how mitochondria operate in eukaryotic 
cells. CLEs powered by light-activated ATP generating proteoliposome may be 
able outlast the current ATP regeneration system. 
 
4.4.2.2 Active transport Molecular motors 
Another possible application is to use the proteoliposome in conjunction with self 
assembly or active transport of microtubules on kinesin tracks. ATP has been 
shown to participate in both the self-assembly of synthetic nano-wires53 as well as 
in the active transport of microtubules leading to polymerisation54. On a general 
level, the introduction of the proteoliposomes will allow the use of light to 
regulate the production of ATP, and keep the system under non-saturating levels 
of ATP. This will allow a much more precise control of self-assembly parameters 
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such as the filament length and rate of polymerisation. It is also envisioned that, 
entrapped in a 2-d or 3-d template, the specific application of a focused light 
source or laser could create a localized increase in ATP concentration that 
encourages the directional growth of the nanowires or microtubules into more 
complex architectures, or enable selective directionality of microtubules traveling 
through junctions in kinesin-coated tracks55.  
 
While not within the scope of our proposed research, these examples highlight the 
how proteoliposome system, as a modular unit, can confer light-driven control of 
ATP synthesis on ATP dependent nano-scale devices. 
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Fig. 34. Fluorophore leakage from the lumen of pyranine encapsulated liposomes and BR-
liposomes into the external medium. Strength of the fluorescence signal at 415 nm excitation 
was measured over 7 days. 
. 
. 
 
 
 
 
 
 
 
 
 
 84 
 
 
 
 
 
 
 
 
 
 
 
 
 
-END- 
 
